Item Type: State Publication

Linked To

Collection

Publication Set

Oregon Health Authority: constraints on Oregon's prescription drug monitoring program limit the state's ability to help address opioid misuse and abuse

State Library of Oregon: Oregon Documents

This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program. It is for informational purposes and may not be suitable for legal purposes.

Tools

Download Add to My Collection Contact us about this Citation for this item

2018 report Oregon Health Authority: constraints on Oregon's prescription drug monitoring program limit the state's ability to help address opioid misuse and abuse

Details

Title2018 report Oregon Health Authority: constraints on Oregon's prescription drug monitoring program limit the state's ability to help address opioid misuse and abuseCorporate NameOregon Audits DivisionOregon Health AuthoritySubjectAuditingAuditingOpioid abuse -- Oregon -- Prevention -- EvaluationOpioid abuse -- Prevention -- Government policy -- OregonDrugs -- Prescribing -- Oregon -- Data processing -- EvaluationDrugs -- Prescribing -- Data processing -- Government policy -- OregonGenrebibliographygovernment publicationtextDate2018CollectionHealth AuthorityAuditsLanguageengPublisherSecretary of State, Oregon Audits DivisionPlace of PublicationSalem, ORFormonline resourceExtent1 online resourceType of ResourcetextIssuancemonographicNoteTitle from PDF cover (viewed on December 12, 2018).This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program. It is for informational purposes and may not be suitable for legal purposes.Includes bibliographical references.Mode of access: Internet from the Oregon Government Publications Collection.Text in English.

Administrative

OCLC NumberCovers OCLC #1333965157, OCLC #1078785684Restrictions on Accesshttp://rightsstatements.org/vocab/CNE/1.0/Publication SetOregon Health Authority: constraints on Oregon's prescription drug monitoring program limit the state's ability to help address opioid misuse and abuse